{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:10Z","timestamp":1787070910536,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>An effective multi-modal treatment option for patients with peritoneal surface metastatic malignancies has progressed and developed over the decades as cytoreductive surgery (CRS), and hyperthermic intra-peritoneal chemotherapy (HIPEC) delivers highly concentrated, heated chemotherapy drugs directly to the abdomen during surgery. Peritoneal metastasis and high staging abdominal malignancies were considered incurable and end up with the palliation only; the CRS+HIPEC combination approach increases the median survival rate and gives a better quality of life to these patients. It is a complicated surgery which poses a high rate of complications and challenges which are difficult to manage and requires a multi-disciplinary approach. The aim of this study is to elaborate the perioperative possible physiological changes, risk factors, and related complications after re-do HIPEC.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_354_22","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T03:05:17Z","timestamp":1708484717000},"page":"S921-S924","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Re-do cytoreductive surgery with hyperthermic intra-peritoneal chemotherapy (HIPEC): Risk factors and complications"],"prefix":"10.4103","volume":"19","author":[{"given":"Namita","family":"Mishra","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbu","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: A pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","article-title":"Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy","volume":"38","author":"Klaver","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: Multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur J Cancer"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6004\/jnccn.2012.0008","article-title":"Current concept in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma","volume":"10","author":"Turner","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3747\/co.v18i2.663","article-title":"A new standard of care for the management of peritoneal surface malignancy","volume":"18","author":"Mohamed","year":"2011","journal-title":"Curr Oncol"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2044.2007.05380.x","article-title":"Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"63","author":"Schmidt","year":"2008","journal-title":"Anaesthesia"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/ANE.0b013e3182860fff","article-title":"An overview of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for the anesthesiologist","volume":"116","author":"Webb","year":"2013","journal-title":"Anesth Analg"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","article-title":"Best practice for perioperative management of patients with cytoreductive surgery\u00b4and HIPEC","volume":"43","author":"Raspe","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ACO.0b013e32835347b2","article-title":"Anesthetic management in patients undergoing hyperthermic chemotherapy","volume":"25","author":"Raspe","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1477-7819-9-169","article-title":"Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)","volume":"9","author":"Cooksley","year":"2011","journal-title":"World J Surg Oncol"},{"key":"R14-20241021","article-title":"Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures","author":"Rachel","year":"2013","journal-title":"Int J Surg Oncol 2013"},{"key":"R15-20241021","first-page":"70","article-title":"Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy","volume":"2","author":"Becher","year":"2011","journal-title":"J Gastrointest Oncol"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/ASO.2003.01.018","article-title":"Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures","volume":"10","author":"Glehen","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","article-title":"Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique","volume":"6","author":"Stephens","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1245\/s10434-007-9406-8","article-title":"Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy\u2013A journey to becoming a nationally funded peritonectomy center","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","article-title":"Extent of colorectal peritoneal carcinomatosis: Attempt to define a threshold above which HIPEC does not offer survival benefit: A comparative study","volume":"22","author":"Goere","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF02602761","article-title":"Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery","volume":"10","author":"Lawrence","year":"1995","journal-title":"J Gen Intern Med"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s10350-005-0045-5","article-title":"Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: A prospective study","volume":"48","author":"Loungnarath","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1245\/s10434-009-0875-9","article-title":"Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"17","author":"Saxena","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12957-020-01837-4","article-title":"Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy- A national population-based study","volume":"18","author":"Dranichnikov","year":"2020","journal-title":"World J Surg Oncol"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12957-021-02276-5","article-title":"Feasibility and outcomes of cytoreductive surgery and HIPEC for pertoneal surface malignancies in low and middle-income countries: A single centre experience of 232 cases","volume":"19","author":"Deo","year":"2021","journal-title":"World J Surg Onc"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1245\/s10434-020-08812-z","article-title":"Prognostic value and risk factors of peritoneal carcinomatosis recurrence for patients with endometrial cancer: A multicentre study from the FRANCOGYN group","volume":"28","author":"Gaudet Chardonnet","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000520330","article-title":"Comparative analysis of postoperative complications after cytoreductive surgery and HIPEC in gastric cancer","volume":"45","author":"Merboth","year":"2022","journal-title":"Oncol Res Treat"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_354_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:45Z","timestamp":1787067525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_354_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_354_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-02-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}